Advertisement · 728 × 90
#
Hashtag
#FGFR
Advertisement · 728 × 90
Post image

We still have a limited number of poster presentation slots available for researchers with new or recently completed work.

🚨 Registration deadline extended to 07 April 2026
🛎️ Places are limited and subject to hotel availability

Register here ➡️ bit.ly/4dcf21Q

#FusionCellBio
#FusionDevBio
#FGFR

0 0 0 0
Post image

🚀From Bench to Paper | A Nature Genetics study maps all functional #FGFR 1–4 kinase mutations via saturation mutagenesis, revealing activating & drug-resistant variants for precision #oncology.
#Puromycin (MedChemExpress) supported high-throughput screening.
www.medchemexpress.com/Puromycin.html

0 0 0 0
Video

El inhibidor de FGFR de Johnson & Johnson, erdafitinib es aprobado para su comercialización en China

📩 info@dengyuemed.com
🔗https://dengyuepharma.com

#Erdafitinib #Balversa #JohnsonAndJohnson #FGFR #FGFR3 #UrothelialCarcinoma #Oncología

0 0 0 0
Preview
Pemigatinib (Pemazyre): Uses in Cancer, Side effects, Dosage, Expectation and more - OncoDaily Learn more about Pemigatinib (Pemazyre), its uses, dosage, side effects, administration, and what to expect during treatment.

Pemigatinib (Pemazyre): Uses in Cancer, Side effects, Dosage, Expectation, and more

oncodaily.com/drugs/pemiga...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Pemigatinib #Pemazyre #FGFR

5 0 0 0
Post image Post image Post image

The phase 2 FIGHT-207 basket trial evaluated pemigatinib, a selective oral FGFR1-3 inhibitor, in previously treated patients with advanced solid tumors harboring activating FGFR1-3 alterations.

@natureportfolio.nature.com

#Onco404 #MedSky #OncSky #Cancer #Kanser #ClinicalTrials #Oncology #FGFR

1 1 1 0
Post image

Tremendous talk by Dr. Kailey Oppat @winshipatemory.bsky.social on #FGFR and #IDH interaction with #immune signatures in #cholangiocarcinoma via collab w #carisls @cholangiocarcinoma.bsky.social annual meeting!

6 0 0 0
Preview
FGFR antagonists restore defective mandibular bone repair in a mouse model of osteochondrodysplasia - Bone Research Bone Research - FGFR antagonists restore defective mandibular bone repair in a mouse model of osteochondrodysplasia

On February 7, 2025, researchers from Université de Paris Cité and the Imagine Institute published a pivotal study in Bone Research, investigating the effects of FGFR antagonists on bone repair in mouse models of osteochondrodysplasia.
#FGFR #Antagonists
Details: doi.org/10.1038/s414...

0 0 0 0